Protalix BioTherapeutics
PLX
#8575
Rank
S$0.16 B
Marketcap
$2.23
Share price
-1.78%
Change (1 day)
18.40%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -S$17.63 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are S$38.05 Million. In 2023 the company made an earning of S$15.81 Million, an increase over its 2022 earnings that were of -S$15.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$17.63 Million-211.48%
2023 S$15.81 M-199.05%
2022 -S$15.97 Million-40.38%
2021 -S$26.78 Million-732.31%
2020 S$4.23 M-130.53%
2019 -S$13.88 Million189.85%
2018 -S$4.79 Million-95.29%
2017 -S$0.11 Billion308.12%
2016 -S$24.91 Million-32.37%
2015 -S$36.83 Million10.11%
2014 -S$33.45 Million-7.59%
2013 -S$36.19 Million
2011 -S$41.91 Million-19.39%
2010 -S$51.99 Million20.87%
2009 -S$43.01 Million32.26%
2008 -S$32.52 Million-5.46%
2007 -S$34.4 Million
2004 -S$0.23 Million12.35%
2003 -S$0.2 Million-11.1%
2002 -S$0.23 Million-57.03%
2001 -S$0.52 Million1.03%
2000 -S$0.52 Million-53.22%
1999 -S$1.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.14 Billion 658.72%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.88 B-5,090.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$1.64 Billion 9,110.43%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.11 B-6,384.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel